This application is submitted in response to NIAAA's program announcement, Behavioral &Integrative Treatment Development Program, PA-10-013 and is consistent with NIH's recent interest in developing adaptive mobile interventions. The proposed development study entitled, Tailored Mobile Text Messaging to Reduce Problem Drinking is designed to develop and test a tailored adaptive text messaging/short message service (SMS) intervention for individuals interested in stopping or reducing their alcool consumption. Excessive alcohol consumption is a serious personal and public health issue and economic problem to society. Despite the significant consequences of problem drinking (PD), most persons with alcohol problems never seek formal treatment. While the emergence of internet based interventions (IBIs) has expanded access and brief intervention opportunities to problem drinkers, traditional IBIs suffer from high attrition, limited ability to proactively meet individuals where PD occurs and adapt to real-time needs. Recent evidence from smoking cessation studies highlight that SMS interventions may provide the needed reinforcement to help individuals enhance self-regulation and reduce problem alcohol use when they need it most in their natural environment. Moreover, because PD typically has regular episodic patterns, tailored interactive designs may be particularly effective. This study is designed to develop and test an interactive adaptive mobile messaging intervention for PD, which includes messages tailored to baseline assessment results (including drinking times) that are adaptive to ongoing drinking patterns and goal achievement via interactive ecological momentary assessment (EMA). Other features include participant initiated help messaging and support network alerts. We will conduct beta research with 40 problem drinkers to assess messaging preferences and acceptability, and then conduct a pilot test with 10 PDs. In Stage 1b, we aim to test this intervention and understand the mechanisms of action of different text messaging interventions with 200 problem drinkers over a 12-week period. We propose to compare four types of messaging: 1) Tailored content and timed messaging adaptive to the participants current state (Stage 1a intervention)~ 2) Tailored content messaging (not adaptive or timed) sent at 3 pm every day~ 3) Untailored consequence based messages sent at 3 pm every day~ and 4) Brief feedback and EMA only. Assessments will be completed at baseline, through weekly EMA via SMS and at week 12 via a web-based follow-up assessment. Primary outcomes include drinks per drinking day, days of heavy drinking, and average drinks per week as measured through weekly EMA. Additional outcomes will include drinking related consequences, goal commitment and intervention satisfaction. Outcomes will be used to modify the intervention and to prepare for a larger Stage 1c RCT.

Public Health Relevance

Excessive alcohol consumption has serious personal and public health consequences. Internet based interventions for problem drinking have proven mildly effective but have limited ability to help individuals maintain changes. Tex messaging interventions can support individuals proactively and be tailored to an individual's current state with real-time interactive features. We propose to create an adaptive tex messaging intervention to reduce alcohol consumption and related problems and test whether tailored adaptive messaging is superior to untailored messaging in a randomized controlled trial. This intervention could be easily disseminated and potentially improve long-term psychosocial and health outcomes for problem drinkers.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Planning Grant (R34)
Project #
1R34AA021502-01
Application #
8364647
Study Section
Health Services Research Review Subcommittee (AA)
Program Officer
Zha, Wenxing
Project Start
2012-08-15
Project End
2015-07-31
Budget Start
2012-08-15
Budget End
2013-07-31
Support Year
1
Fiscal Year
2012
Total Cost
$229,713
Indirect Cost
$85,963
Name
New York State Psychiatric Institute
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Qiao, Yuyang; Jia, Ben; Hu, Zhiqiang et al. (2018) MetaBinG2: a fast and accurate metagenomic sequence classification system for samples with many unknown organisms. Biol Direct 13:15
Zhang, Bin; Ye, Bang-Ce (2018) Pathway engineering in Corynebacterium glutamicum S9114 for 5-aminolevulinic acid production. 3 Biotech 8:247
Chen, Xiaowei; Fan, Zhen; McGee, Warren et al. (2018) TDP-43 regulates cancer-associated microRNAs. Protein Cell 9:848-866
Zhong, Chaofang; Han, Maozhen; Yu, Shaojun et al. (2018) Pan-genome analyses of 24 Shewanella strains re-emphasize the diversification of their functions yet evolutionary dynamics of metal-reducing pathway. Biotechnol Biofuels 11:193
Kuerbis, Alexis; van Stolk-Cooke, Katherine; Muench, Frederick J (2017) Characteristics of online treatment seekers interested in a text messaging intervention for problem drinking: adults 51 and older versus middle-aged and younger adults. Ment Health Addict Res 2:
Kuerbis, Alexis; van Stolk-Cooke, Katherine; Muench, Frederick (2017) An exploratory study of mobile messaging preferences by age: Middle-aged and older adults compared to younger adults. J Rehabil Assist Technol Eng 4:
Sucala, Madalina; Nilsen, Wendy; Muench, Frederick (2017) Building partnerships: a pilot study of stakeholders' attitudes on technology disruption in behavioral health delivery and research. Transl Behav Med 7:854-860
Muench, Frederick; Baumel, Amit (2017) More Than a Text Message: Dismantling Digital Triggers to Curate Behavior Change in Patient-Centered Health Interventions. J Med Internet Res 19:e147
Song, Dong; Wang, Wei; Ye, Wei et al. (2017) ff14IDPs force field improving the conformation sampling of intrinsically disordered proteins. Chem Biol Drug Des 89:5-15
Wang, Yin-Ying; Bai, Hong; Zhang, Run-Zhi et al. (2017) Predicting new indications of compounds with a network pharmacology approach: Liuwei Dihuang Wan as a case study. Oncotarget 8:93957-93968

Showing the most recent 10 out of 29 publications